Search results
Healthcare's Hope in Artificial Intelligence
Medscape· 3 days agoAI is coming for healthcare, and that's a good thing.
India's Sun Pharma beats Q4 profit view on strong US, domestic sales
Reuters via Yahoo Finance· 5 days agoSun Pharma's U.S. sales rose nearly 11.9% to 39.54 billion rupees, boosted by speciality complex...
Your risk factor for heart attack: How University Hospitals' free calcium score test could save your...
WKYC Cleveland· 5 days agoFor several years now, University Hospitals has been offering free calcium score tests that can help...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace via Yahoo Finance· 7 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 6 days agoThe board will seek public comments, additional information and data over the next 60 days to...
Poor Sleep in Kids Tied to Psychosis Risk in Adulthood
Medscape· 5 days agoPersistently short sleep during childhood has been linked to a more than twofold increased risk for...
Palisade's ulcerative colitis drug prevents symptoms in mice, is nontoxic in dogs
FierceBiotech· 4 days agoTwice-daily doses of Palisade's oral prodrug PALI-2108 for eight days protected mouse models of...
Stress can be "the triggering factor" for skin problems. Dermatologists share their advice.
CBS News· 6 days agoThere are many ways mental health can impact our physical health — but did you know stress can even...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 5 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
Tracking down the genetic causes of lupus to personalize treatment
Medical Xpress· 4 days agoResearchers are just now beginning to link specific genetic mutations to subsets of lupus patients, allowing physicians to target therapies to those who will benefit most. In the latest advance ...